SlideShare a Scribd company logo
Science Park and cluster managing company
focused on life sciences and health, created with
the support of Regione Piemonte in the EU
programs framework (beginning 90’s) -
Operational since 1998.
§ 25.000 sqm labs, office spaces
§ R&D shared facilities and services
§ Support and acceleration of start-up/spin
off
§ Consultancy in biomanagement
§ Networking and clustering(bioPmed)
§ Conference centre
www.bioindustrypark.eu
Key elements
Bioindustry Park
Silvano Fumero
The Bioindustry Park
value creation process
From the identification of promising scientific
results to the growth of a successful company:
• Incubation
• Acceleration
• Settlements
• Managerial consulting
• Clustering
• International projects
• Scientific support (outsourced)
Incubation and company
acceleration
Facility management
and General services
for lessees
Exploitation of
scientific results and
scientific services
Consulting, TT
support, Cluster
development and
International
projects
The Italian health
care system
• In 2000 Italy's healthcare system was regarded,
by World Health Organization's ranking, as the
2nd best in the world after France
• Healthcare is provided to all citizens and
residents by a mixed public-private system. The
public part is the national health service,
“Sistema sanitario nazionale (SSN)”, which is
organized under the Ministry of Health and is
administered on a regional basis.
The vision for the future
of health management
Strategic Trajectories
Areas of Scientific
& Industrial Interest
Ageing and
chronic
pathologies
Converging
technologies
Personalised
approach and
integration of
therapy
/diagnosis
New
diagnostic
systems
Prevention
Innovative
medicines and
therapeutic
approaches
E-Health
• “”4Ps” paradigm approach
• “Patient-centric” approach
• “Value based” approach
Health care ecosystem
Source: https://www.linkedin.com/pulse/rise-chief-
ecosystem-officer-new-leaders-innovation-health-lawer
“4Ps” paradigm
Prevention
Prediction
Personalisation
Participation
Personalised
healthcare
approach
Source:
Personalised medicine
• Genetically-determined drug response
variability
• Increased safety and efficacy
• Pharmacogenetics represents an
‘evolution’ not a ‘revolution’ in
medicine
• Increased presence of personalised
medicine, not just at a genetic level
“Disruptive” role of IT
▫Innovation and change element:
▫Management/analysis/visualization
of data;
▫“Ubiquitous” health management;
▫ IoT;
Source: http://qnphc.org/personalized-health-care/
Consequences
on the health system
• Citizens are considered in general if they
have a disease
• Patients are not empowered
• Hospitalization is the “usual” way to manage
care
• Private providers are a “premium” or a “low
cost”choice and they are solution suppliers
• Health care is based on cost management
• The citizen is considered life long
• “4ps” approach: hospitalization for
acute phases and personalized
treatment
• Advanced prevention, diagnostic,
monitoring systems
• New role for families, society and
private providers
• Health care is based on value
management
Prevention and care management
health care models
Acute phase health care models
Consequences at
patient level
Elements:
• Patient Empowerment
• Life long health management
• Prevention/prediction as priority
• …….
Issues:
• Privacy
• Decision power
• Cost/sustainability
• ……..
Potential opportunities for companies
4P
Agening Cost
pressure
Patient
empowerment
4P paradig
Potential opportunities for companies
New market and innovation spaces and segments e.g.
Biotech and combined products (therapeutics and diagnostics)
Telemonitoring
Private diagnostic services
New models to “manage” elderly
Prediction through analysis of genomic data
Wereables and implantables devices
Social innovation solutions for chronic diseases
A possible example…
Source: Josip Car, Woan Shin Tan, Zhilian Huang, Peter Sloot and Bryony Dean Franklin “eHealth in the future of medications management:
personalisation, monitoring and adherence”, BMC Medicine201715:73
Meet In Italy for Life Sciences
It is the team that wins, not
the single player
Bioindustry Park Silvano Fumero SpA
bioPmed Health Cluster
Via Ribes, 5
10010 Colleretto Giacosa (TO)
Italy
Tel. +39-0125-561311
www.bioindustrypark.eu
Info@bioindustrypark.it
www.biopmed.eu
info@biopmed.eu
Fabrizio Conicella
conicella@bioindustrypark.it
Thank you

More Related Content

Similar to From prevention to the chronic patient management

Colloque IMT - 15/10/2019 - Healthcare 4.0 – « EIT Health : un tremplin europ...
Colloque IMT - 15/10/2019 - Healthcare 4.0 – « EIT Health : un tremplin europ...Colloque IMT - 15/10/2019 - Healthcare 4.0 – « EIT Health : un tremplin europ...
Colloque IMT - 15/10/2019 - Healthcare 4.0 – « EIT Health : un tremplin europ...
I MT
 
Finn Medi Presentation study visit (Life Sciences Sector)
Finn Medi Presentation study visit (Life Sciences Sector)Finn Medi Presentation study visit (Life Sciences Sector)
Finn Medi Presentation study visit (Life Sciences Sector)
TR3S PROJECT
 
Alpha One Conference - IPPOSI
Alpha One Conference - IPPOSIAlpha One Conference - IPPOSI
Alpha One Conference - IPPOSI
ipposi
 
Marcel de Pender, Slimmer Leven 2010 “Regional Strategy in The Province Noord...
Marcel de Pender, Slimmer Leven 2010 “Regional Strategy in The Province Noord...Marcel de Pender, Slimmer Leven 2010 “Regional Strategy in The Province Noord...
Marcel de Pender, Slimmer Leven 2010 “Regional Strategy in The Province Noord...
Mindtrek
 
EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017
ipposi
 
10.e John Rayner - " Por un modelo de evaluación para la implantación de aten...
10.e John Rayner - " Por un modelo de evaluación para la implantación de aten...10.e John Rayner - " Por un modelo de evaluación para la implantación de aten...
10.e John Rayner - " Por un modelo de evaluación para la implantación de aten...
Badalona Serveis Assistencials
 
Kevin Conlon ehealth Strategy, Department of Health
Kevin Conlon ehealth Strategy, Department of HealthKevin Conlon ehealth Strategy, Department of Health
Kevin Conlon ehealth Strategy, Department of Health
Investnet
 
Who Healthy Cities - Innovating for Health and Well-being
Who Healthy Cities - Innovating for Health and Well-beingWho Healthy Cities - Innovating for Health and Well-being
Who Healthy Cities - Innovating for Health and Well-being
Games for Health Finland
 
PPI Conference Galway April 2017 - Dr Derick Mitchell
PPI Conference Galway April 2017 - Dr Derick MitchellPPI Conference Galway April 2017 - Dr Derick Mitchell
PPI Conference Galway April 2017 - Dr Derick Mitchell
ipposi
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
jangeissler
 
Patient-Centered Digital Health
Patient-Centered Digital HealthPatient-Centered Digital Health
Patient-Centered Digital Health
ipposi
 
EU Clinical Trials Regulation - IPPOSI perspective
EU Clinical Trials Regulation - IPPOSI perspectiveEU Clinical Trials Regulation - IPPOSI perspective
EU Clinical Trials Regulation - IPPOSI perspective
ipposi
 
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the InternetJan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
patvocates
 
MAPS2018 Keynote address on EY report: Life Sciences 4.0 – Securing value thr...
MAPS2018 Keynote address on EY report: Life Sciences 4.0 – Securing value thr...MAPS2018 Keynote address on EY report: Life Sciences 4.0 – Securing value thr...
MAPS2018 Keynote address on EY report: Life Sciences 4.0 – Securing value thr...
EY
 
Derick Mitchell_Biobanking from the patient perspective.pdf
Derick Mitchell_Biobanking from the patient perspective.pdfDerick Mitchell_Biobanking from the patient perspective.pdf
Derick Mitchell_Biobanking from the patient perspective.pdf
ipposi
 
Examples of latest solutions in health care developments in Finland and in Ku...
Examples of latest solutions in health care developments in Finland and in Ku...Examples of latest solutions in health care developments in Finland and in Ku...
Examples of latest solutions in health care developments in Finland and in Ku...
Games for Health Finland
 
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pptx
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pptxSession_3_Meet_Some_of_the_Most_Innovative_Hospitals.pptx
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pptx
KapoorSonam
 
mHealth Israel_Allianz_Steffen Krotsch_eHealth at Allianz Group
mHealth Israel_Allianz_Steffen Krotsch_eHealth at Allianz GroupmHealth Israel_Allianz_Steffen Krotsch_eHealth at Allianz Group
mHealth Israel_Allianz_Steffen Krotsch_eHealth at Allianz Group
Levi Shapiro
 
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pdf
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pdfSession_3_Meet_Some_of_the_Most_Innovative_Hospitals.pdf
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pdf
ArshaqKN
 
Presentation 1.0
Presentation 1.0Presentation 1.0
Presentation 1.0
Gene Rosov
 

Similar to From prevention to the chronic patient management (20)

Colloque IMT - 15/10/2019 - Healthcare 4.0 – « EIT Health : un tremplin europ...
Colloque IMT - 15/10/2019 - Healthcare 4.0 – « EIT Health : un tremplin europ...Colloque IMT - 15/10/2019 - Healthcare 4.0 – « EIT Health : un tremplin europ...
Colloque IMT - 15/10/2019 - Healthcare 4.0 – « EIT Health : un tremplin europ...
 
Finn Medi Presentation study visit (Life Sciences Sector)
Finn Medi Presentation study visit (Life Sciences Sector)Finn Medi Presentation study visit (Life Sciences Sector)
Finn Medi Presentation study visit (Life Sciences Sector)
 
Alpha One Conference - IPPOSI
Alpha One Conference - IPPOSIAlpha One Conference - IPPOSI
Alpha One Conference - IPPOSI
 
Marcel de Pender, Slimmer Leven 2010 “Regional Strategy in The Province Noord...
Marcel de Pender, Slimmer Leven 2010 “Regional Strategy in The Province Noord...Marcel de Pender, Slimmer Leven 2010 “Regional Strategy in The Province Noord...
Marcel de Pender, Slimmer Leven 2010 “Regional Strategy in The Province Noord...
 
EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017
 
10.e John Rayner - " Por un modelo de evaluación para la implantación de aten...
10.e John Rayner - " Por un modelo de evaluación para la implantación de aten...10.e John Rayner - " Por un modelo de evaluación para la implantación de aten...
10.e John Rayner - " Por un modelo de evaluación para la implantación de aten...
 
Kevin Conlon ehealth Strategy, Department of Health
Kevin Conlon ehealth Strategy, Department of HealthKevin Conlon ehealth Strategy, Department of Health
Kevin Conlon ehealth Strategy, Department of Health
 
Who Healthy Cities - Innovating for Health and Well-being
Who Healthy Cities - Innovating for Health and Well-beingWho Healthy Cities - Innovating for Health and Well-being
Who Healthy Cities - Innovating for Health and Well-being
 
PPI Conference Galway April 2017 - Dr Derick Mitchell
PPI Conference Galway April 2017 - Dr Derick MitchellPPI Conference Galway April 2017 - Dr Derick Mitchell
PPI Conference Galway April 2017 - Dr Derick Mitchell
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
 
Patient-Centered Digital Health
Patient-Centered Digital HealthPatient-Centered Digital Health
Patient-Centered Digital Health
 
EU Clinical Trials Regulation - IPPOSI perspective
EU Clinical Trials Regulation - IPPOSI perspectiveEU Clinical Trials Regulation - IPPOSI perspective
EU Clinical Trials Regulation - IPPOSI perspective
 
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the InternetJan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
 
MAPS2018 Keynote address on EY report: Life Sciences 4.0 – Securing value thr...
MAPS2018 Keynote address on EY report: Life Sciences 4.0 – Securing value thr...MAPS2018 Keynote address on EY report: Life Sciences 4.0 – Securing value thr...
MAPS2018 Keynote address on EY report: Life Sciences 4.0 – Securing value thr...
 
Derick Mitchell_Biobanking from the patient perspective.pdf
Derick Mitchell_Biobanking from the patient perspective.pdfDerick Mitchell_Biobanking from the patient perspective.pdf
Derick Mitchell_Biobanking from the patient perspective.pdf
 
Examples of latest solutions in health care developments in Finland and in Ku...
Examples of latest solutions in health care developments in Finland and in Ku...Examples of latest solutions in health care developments in Finland and in Ku...
Examples of latest solutions in health care developments in Finland and in Ku...
 
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pptx
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pptxSession_3_Meet_Some_of_the_Most_Innovative_Hospitals.pptx
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pptx
 
mHealth Israel_Allianz_Steffen Krotsch_eHealth at Allianz Group
mHealth Israel_Allianz_Steffen Krotsch_eHealth at Allianz GroupmHealth Israel_Allianz_Steffen Krotsch_eHealth at Allianz Group
mHealth Israel_Allianz_Steffen Krotsch_eHealth at Allianz Group
 
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pdf
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pdfSession_3_Meet_Some_of_the_Most_Innovative_Hospitals.pdf
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pdf
 
Presentation 1.0
Presentation 1.0Presentation 1.0
Presentation 1.0
 

More from Coppa+Landini

Food trend 2018 abstract gellify
Food trend 2018 abstract gellifyFood trend 2018 abstract gellify
Food trend 2018 abstract gellify
Coppa+Landini
 
Progettare esperienze per emozionare. La transizione dalla UX alla UI.
Progettare esperienze per emozionare. La transizione dalla UX alla UI.Progettare esperienze per emozionare. La transizione dalla UX alla UI.
Progettare esperienze per emozionare. La transizione dalla UX alla UI.
Coppa+Landini
 
UX: chi, come, cosa e perché
UX: chi, come, cosa e perchéUX: chi, come, cosa e perché
UX: chi, come, cosa e perché
Coppa+Landini
 
UX e UI: buone pratiche e strumenti
UX e UI: buone pratiche e strumenti UX e UI: buone pratiche e strumenti
UX e UI: buone pratiche e strumenti
Coppa+Landini
 
La comunicazione interna nell'era multicanale
La comunicazione interna nell'era multicanaleLa comunicazione interna nell'era multicanale
La comunicazione interna nell'era multicanale
Coppa+Landini
 
L'intelligenza artificiale al servizio dell'HR
L'intelligenza artificiale al servizio dell'HRL'intelligenza artificiale al servizio dell'HR
L'intelligenza artificiale al servizio dell'HR
Coppa+Landini
 
L'agenda dell'HR per la digital transformation: presentazione della survey
L'agenda dell'HR per la digital transformation: presentazione della surveyL'agenda dell'HR per la digital transformation: presentazione della survey
L'agenda dell'HR per la digital transformation: presentazione della survey
Coppa+Landini
 
HR digitalization: processi e progetti
HR digitalization: processi e progetti HR digitalization: processi e progetti
HR digitalization: processi e progetti
Coppa+Landini
 
L'ecosistema digitale di Siemens Healthineers: dall'analisi del dato alla med...
L'ecosistema digitale di Siemens Healthineers: dall'analisi del dato alla med...L'ecosistema digitale di Siemens Healthineers: dall'analisi del dato alla med...
L'ecosistema digitale di Siemens Healthineers: dall'analisi del dato alla med...
Coppa+Landini
 
Informatica e Genetica per una vera precision medicine
Informatica e Genetica per una vera precision medicine Informatica e Genetica per una vera precision medicine
Informatica e Genetica per una vera precision medicine
Coppa+Landini
 
Sistemi indossabili per la salute e il benessere della persona
Sistemi indossabili per la salute e il benessere della personaSistemi indossabili per la salute e il benessere della persona
Sistemi indossabili per la salute e il benessere della persona
Coppa+Landini
 
aXurge: la matematica va in corsia
aXurge: la matematica va in corsia aXurge: la matematica va in corsia
aXurge: la matematica va in corsia
Coppa+Landini
 
Trend analysis in healthcare
Trend analysis in healthcare Trend analysis in healthcare
Trend analysis in healthcare
Coppa+Landini
 
Message in a chatbot. I bot tra hype e realtà, come interfaccia conversaziona...
Message in a chatbot. I bot tra hype e realtà, come interfaccia conversaziona...Message in a chatbot. I bot tra hype e realtà, come interfaccia conversaziona...
Message in a chatbot. I bot tra hype e realtà, come interfaccia conversaziona...
Coppa+Landini
 
Quando l'umanità non servirà più
Quando l'umanità non servirà piùQuando l'umanità non servirà più
Quando l'umanità non servirà più
Coppa+Landini
 
Vocal interaction & chatbot
Vocal interaction & chatbot Vocal interaction & chatbot
Vocal interaction & chatbot
Coppa+Landini
 
La nuova era dei robots: grandi opportunità e rischi
La nuova era dei robots: grandi opportunità e rischiLa nuova era dei robots: grandi opportunità e rischi
La nuova era dei robots: grandi opportunità e rischi
Coppa+Landini
 
Mappe e algoritmi
Mappe e algoritmi Mappe e algoritmi
Mappe e algoritmi
Coppa+Landini
 
Map interfaces
Map interfaces Map interfaces
Map interfaces
Coppa+Landini
 
Costruire mappe per i progetti di territorio: interpretare contesti e "comunità"
Costruire mappe per i progetti di territorio: interpretare contesti e "comunità"Costruire mappe per i progetti di territorio: interpretare contesti e "comunità"
Costruire mappe per i progetti di territorio: interpretare contesti e "comunità"
Coppa+Landini
 

More from Coppa+Landini (20)

Food trend 2018 abstract gellify
Food trend 2018 abstract gellifyFood trend 2018 abstract gellify
Food trend 2018 abstract gellify
 
Progettare esperienze per emozionare. La transizione dalla UX alla UI.
Progettare esperienze per emozionare. La transizione dalla UX alla UI.Progettare esperienze per emozionare. La transizione dalla UX alla UI.
Progettare esperienze per emozionare. La transizione dalla UX alla UI.
 
UX: chi, come, cosa e perché
UX: chi, come, cosa e perchéUX: chi, come, cosa e perché
UX: chi, come, cosa e perché
 
UX e UI: buone pratiche e strumenti
UX e UI: buone pratiche e strumenti UX e UI: buone pratiche e strumenti
UX e UI: buone pratiche e strumenti
 
La comunicazione interna nell'era multicanale
La comunicazione interna nell'era multicanaleLa comunicazione interna nell'era multicanale
La comunicazione interna nell'era multicanale
 
L'intelligenza artificiale al servizio dell'HR
L'intelligenza artificiale al servizio dell'HRL'intelligenza artificiale al servizio dell'HR
L'intelligenza artificiale al servizio dell'HR
 
L'agenda dell'HR per la digital transformation: presentazione della survey
L'agenda dell'HR per la digital transformation: presentazione della surveyL'agenda dell'HR per la digital transformation: presentazione della survey
L'agenda dell'HR per la digital transformation: presentazione della survey
 
HR digitalization: processi e progetti
HR digitalization: processi e progetti HR digitalization: processi e progetti
HR digitalization: processi e progetti
 
L'ecosistema digitale di Siemens Healthineers: dall'analisi del dato alla med...
L'ecosistema digitale di Siemens Healthineers: dall'analisi del dato alla med...L'ecosistema digitale di Siemens Healthineers: dall'analisi del dato alla med...
L'ecosistema digitale di Siemens Healthineers: dall'analisi del dato alla med...
 
Informatica e Genetica per una vera precision medicine
Informatica e Genetica per una vera precision medicine Informatica e Genetica per una vera precision medicine
Informatica e Genetica per una vera precision medicine
 
Sistemi indossabili per la salute e il benessere della persona
Sistemi indossabili per la salute e il benessere della personaSistemi indossabili per la salute e il benessere della persona
Sistemi indossabili per la salute e il benessere della persona
 
aXurge: la matematica va in corsia
aXurge: la matematica va in corsia aXurge: la matematica va in corsia
aXurge: la matematica va in corsia
 
Trend analysis in healthcare
Trend analysis in healthcare Trend analysis in healthcare
Trend analysis in healthcare
 
Message in a chatbot. I bot tra hype e realtà, come interfaccia conversaziona...
Message in a chatbot. I bot tra hype e realtà, come interfaccia conversaziona...Message in a chatbot. I bot tra hype e realtà, come interfaccia conversaziona...
Message in a chatbot. I bot tra hype e realtà, come interfaccia conversaziona...
 
Quando l'umanità non servirà più
Quando l'umanità non servirà piùQuando l'umanità non servirà più
Quando l'umanità non servirà più
 
Vocal interaction & chatbot
Vocal interaction & chatbot Vocal interaction & chatbot
Vocal interaction & chatbot
 
La nuova era dei robots: grandi opportunità e rischi
La nuova era dei robots: grandi opportunità e rischiLa nuova era dei robots: grandi opportunità e rischi
La nuova era dei robots: grandi opportunità e rischi
 
Mappe e algoritmi
Mappe e algoritmi Mappe e algoritmi
Mappe e algoritmi
 
Map interfaces
Map interfaces Map interfaces
Map interfaces
 
Costruire mappe per i progetti di territorio: interpretare contesti e "comunità"
Costruire mappe per i progetti di territorio: interpretare contesti e "comunità"Costruire mappe per i progetti di territorio: interpretare contesti e "comunità"
Costruire mappe per i progetti di territorio: interpretare contesti e "comunità"
 

Recently uploaded

KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 

Recently uploaded (20)

KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 

From prevention to the chronic patient management

  • 1.
  • 2. Science Park and cluster managing company focused on life sciences and health, created with the support of Regione Piemonte in the EU programs framework (beginning 90’s) - Operational since 1998. § 25.000 sqm labs, office spaces § R&D shared facilities and services § Support and acceleration of start-up/spin off § Consultancy in biomanagement § Networking and clustering(bioPmed) § Conference centre www.bioindustrypark.eu Key elements Bioindustry Park Silvano Fumero
  • 3. The Bioindustry Park value creation process From the identification of promising scientific results to the growth of a successful company: • Incubation • Acceleration • Settlements • Managerial consulting • Clustering • International projects • Scientific support (outsourced) Incubation and company acceleration Facility management and General services for lessees Exploitation of scientific results and scientific services Consulting, TT support, Cluster development and International projects
  • 4. The Italian health care system • In 2000 Italy's healthcare system was regarded, by World Health Organization's ranking, as the 2nd best in the world after France • Healthcare is provided to all citizens and residents by a mixed public-private system. The public part is the national health service, “Sistema sanitario nazionale (SSN)”, which is organized under the Ministry of Health and is administered on a regional basis.
  • 5. The vision for the future of health management Strategic Trajectories Areas of Scientific & Industrial Interest Ageing and chronic pathologies Converging technologies Personalised approach and integration of therapy /diagnosis New diagnostic systems Prevention Innovative medicines and therapeutic approaches E-Health • “”4Ps” paradigm approach • “Patient-centric” approach • “Value based” approach
  • 6. Health care ecosystem Source: https://www.linkedin.com/pulse/rise-chief- ecosystem-officer-new-leaders-innovation-health-lawer
  • 8. Personalised medicine • Genetically-determined drug response variability • Increased safety and efficacy • Pharmacogenetics represents an ‘evolution’ not a ‘revolution’ in medicine • Increased presence of personalised medicine, not just at a genetic level
  • 9. “Disruptive” role of IT ▫Innovation and change element: ▫Management/analysis/visualization of data; ▫“Ubiquitous” health management; ▫ IoT; Source: http://qnphc.org/personalized-health-care/
  • 10. Consequences on the health system • Citizens are considered in general if they have a disease • Patients are not empowered • Hospitalization is the “usual” way to manage care • Private providers are a “premium” or a “low cost”choice and they are solution suppliers • Health care is based on cost management • The citizen is considered life long • “4ps” approach: hospitalization for acute phases and personalized treatment • Advanced prevention, diagnostic, monitoring systems • New role for families, society and private providers • Health care is based on value management Prevention and care management health care models Acute phase health care models
  • 11. Consequences at patient level Elements: • Patient Empowerment • Life long health management • Prevention/prediction as priority • ……. Issues: • Privacy • Decision power • Cost/sustainability • ……..
  • 12. Potential opportunities for companies 4P Agening Cost pressure Patient empowerment 4P paradig
  • 13. Potential opportunities for companies New market and innovation spaces and segments e.g. Biotech and combined products (therapeutics and diagnostics) Telemonitoring Private diagnostic services New models to “manage” elderly Prediction through analysis of genomic data Wereables and implantables devices Social innovation solutions for chronic diseases
  • 14. A possible example… Source: Josip Car, Woan Shin Tan, Zhilian Huang, Peter Sloot and Bryony Dean Franklin “eHealth in the future of medications management: personalisation, monitoring and adherence”, BMC Medicine201715:73
  • 15. Meet In Italy for Life Sciences
  • 16. It is the team that wins, not the single player Bioindustry Park Silvano Fumero SpA bioPmed Health Cluster Via Ribes, 5 10010 Colleretto Giacosa (TO) Italy Tel. +39-0125-561311 www.bioindustrypark.eu Info@bioindustrypark.it www.biopmed.eu info@biopmed.eu Fabrizio Conicella conicella@bioindustrypark.it Thank you